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< first level heading > Abstract 
Key words: intensive care, sleep disruption, sound levels, illuminance levels 
<second level heading> Purpose 
The aim of the current study was to describe the extrinsic and intrinsic factors affecting sleep in 
critically ill patients and examine potential relationships with sleep quality.  
<second level heading> Materials and Methods 
Sleep was recorded using polysomnography and self-reports collected in adult patients in intensive 
care. Sound and illuminance levels were recorded during sleep recording. Objective sleep quality was 
quantified using total sleep time divided by the number of sleep periods (PSG sleep period time ratio). 
A regression model was specified using the ‘PSG sleep period time ratio’ as the dependent variable.  
<second level heading> Results 
Sleep was highly fragmented. Patients rated noise and light as most sleep disruptive. Continuous 
equivalent sound levels were 56 dB(A). Median daytime illuminance level was 74 lux and night-time 
levels were 1 lux. The regression model explained 25% of the variance in sleep quality (p =0.027); the 
presence of an artificial airway was the only statistically significant predictor in the model (p = 0.007). 
<second level heading> Conclusions 
The presence of an artificial airway during sleep monitoring was the only significant predictor in the 
regression model and may suggest that although potentially uncomfortable, an artificial airway may 
actually promote sleep. This requires further investigation. 
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< first level heading > Introduction 
Patients treated in intensive care units (ICU) frequently experience poor quality sleep (1, 2). The 
quantity of sleep may be acceptable but it is highly fragmented, thus stage 1 and 2 sleep is prolonged 
and slow wave and rapid eye movement (REM) sleep is short (1, 2). A multitude of extrinsic and 
intrinsic sleep disruptive factors many of which are interrelated may be responsible for sleep 
disruption in ICU patients (3). Intrinsic factors are patient related and include prehospital sleep quality, 
the inflammatory response, pain and circadian rhythm disruption.  
Polysomnographic (PSG) sleep data and data for variables potentially associated with sleep 
disruption (for example environmental sound and illuminance levels) were collected from 53 ICU 
patients (1). In order to devise and test future interventions to improve sleep in ICU patients we 
planned to analyse the data to explore the relative effect of these factors on sleep arousals but as 
sleep was highly fragmented (median sleep period without waking: 3 m) other methods of analysis 
were necessary to explore factors that disrupt sleep in ICU patients. We sought to model sleep 
disruption in this cohort of ICU patients. Thus the aim of the current study was to describe the 
extrinsic and intrinsic factors affecting sleep in critically ill patients and specifically to: 
a. Examine the relationships between the extrinsic and intrinsic factors affecting sleep 
and sleep quality  
b. Develop a regression model to explain the variance in sleep quality in ICU patients 
< first level heading > Methods 
< second level heading > Participants and setting 
Adult ICU patients older than 17 years with an anticipated ICU length of stay greater than 24 hours 
were invited to participate. Exclusion criteria were: history or evidence of sleep disorder (e.g. 
obstructive sleep apnoea), history or evidence of psychiatric illness, known diagnosis of dementia, 
drug or alcohol withdrawal at time of screening and central neurological impairment (e.g. brain trauma 
confirmed by scan, hypoxic brain injury, suspected encephalopathy, seizure disorder or drug 
overdose).  
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The study was conducted in a 36 bed general and cardiothoracic adult ICU at a 600 bed metropolitan 
hospital in Sydney, Australia. This hospital was a tertiary referral facility for specialty services such as 
cardiac, spinal, renal, neuroscience and burns. Twenty-four hour sleep recording (PSG) took place in 
five of the eight patient rooms in the ICU. Approval to conduct the study was provided by the Human 
Research Ethics Committees for the Hospital (protocol number: 0809-201M(SP)) and the University. 
Patients gave informed consent to participate which was confirmed by their closest proxy who also 
provided written informed consent. The sleep data collected from participants and some 
environmental sound and illuminance level data collected in this study have been previously 
published (1). This paper contains additional information about the data concerning sleep disruptive 
factors and their relationship(s) to sleep quality. 
< second level heading > Instrumentation 
< third level heading > Sleep measurement 
Sleep was measured objectively using polysomnography (PSG) for one 24 hour period (this protocol 
is described elsewhere (1)) and subjectively at the conclusion of PSG monitoring and in the hospital 
ward. Patients self reported on the quality their sleep before hospitalisation (Insomnia Severity Index 
(ISI) (4) and responded to a question in the Sleep in Intensive Care Questionnaire (SICQ) (5)), in ICU 
(using the Richards Campbell Sleep Questionnaire (RSCQ) (6)) and on the Hospital ward (RCSQ and 
SICQ)). 
Insomnia Severity Index: The ISI was developed to identify clinically significant insomnia (based on 
Diagnostic and Statistical Manual of Mental Disorders 4
th 
Edition (DSM-IV) (7) diagnostic criteria for 
the condition). Concurrent validity (r =0.65) was investigated in unpublished work by Morin and 
reported by Bastien, Vallières et al. (4). Lower scores on this instrument indicate better sleep (a cut off 
score of 15 is indicative of significant sleep difficulty). 
Sleep in Intensive Care Questionnaire: The SICQ was administered to assess the patients’ perception 
of sleep disturbances and their sleep in the ICU. The SICQ (5) contains seven questions, some with 
more than one item. Responders are requested to rate their overall sleep quality at home and in the 
ICU (and at three different times during their stay) using the SICQ. In addition, ratings on daytime 
sleepiness are included, along with sources of perceived sleep disruption and noise. Items are rated 
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on a scale one to ten. Ten is the most desirable score for items contained in questions one to five and 
one is the most desirable score for items in questions six to seven. The SICQ was developed in the 
1990s in North America to assess ICU patients’ sleep quality and the factors which contributed to 
sleep disruption while they were in ICU (5). There are no reports of formal validation or psychometric 
tests of the SICQ. However the authors performed pilot testing on 43 patients and as a consequence 
added question seven regarding noise disruption.  
Richards Campbell Sleep Questionnaire: The RCSQ (6) comprises five 100mm visual analogue 
scales: sleep depth, latency, awakenings, time awake and quality of sleep. Responses are scored by 
measuring the distance from the low end of the scale to the mark made by the patient. The total score 
for the RCSQ is calculated by adding the score for each VAS and dividing by five. High scores 
indicate good quality sleep.  
The RCSQ was pilot tested in a medical ICU (n=9, 100% male, 14 nights, (8)) and validated in a more 
extensive investigation involving 70 male patients (6). The correlation between total RCSQ score and 
PSG sleep efficiency index (SEI) was moderate, r = 0.58 (p<0.001); the total RCSQ score was able to 
predict 33% of the variance in the SEI (6). There are no published RCSQ data for healthy individuals 
on which to base a comparison or provide cut off scores for poor, moderate or good sleep.  
< third level heading > Sound level measurement 
A portable sound level meter (SLM) and analyzer (Model 2250) (meeting international standard IEC 
61672-1), microphone (Model 4189) attached to a 3.0 metre extension lead and calibrator (Model 
4231) (Brüel and Kjaer™, Denmark) were used. Sound level meter software BZ7222 ver 1.5, 
Frequency analysis software BZ7223 ver 1.5 and logging software BZ7224 ver 1.4.1 were used (Brüel 
and Kjaer™, Denmark). The SLM was programmed to record sound pressure broadband parameters 
along with LZ spectra at a sampling and logging frequency of one sample per second for 24 hours 
during PSG recording. Maximum input level was 141.07 dB and 1/3 octave bandwidth was used for 
the sound spectra. The ‘Logging’ mode was used. Calibration was performed prior to each study at 
1,000Hz, 94dB as a reference output. The microphone was placed approximately one metre above 
the patient’s head in order to record the sound level the patient was exposed to. 
< third level heading > Illuminance level measurement 
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The T-10 illuminance meter (Minolta™) was used to record light levels throughout the 24 hour PSG 
data collection period. The T-10 is an illuminance meter used by light engineers. It was attached to 
the laptop computer via a serial port to USB port converter. Automatic calibration occurred when the 
meter was switched on. A one minute sampling and recording period was used. The illuminance 
meter sensor was placed on the pillow beside the patient’s head in order to record the illuminance 
level the patient was exposed to as accurately as possible. 
< Second level heading > Data management and analysis  
Clinical and demographic data analysed using SPSS™. Sound level reports were generated using the 
Utility software for Handheld Analyzers BZ 5503 (Brüel and Kjaer™). Sound and illuminance level 
data were analysed using Excel™ (Microsoft™). Summary statistics (median sound level for the entire 
recording, 21.00 - 06.00hrs and 06.00 – 21.00hrs) were calculated. 
Normally distributed continuous data were described using means and standard deviations and non-
normally distributed continuous data were described using medians and interquartile ranges. 
Categorical data were described using frequencies and percentages. Correlation coefficients 
(Pearson (r) for normally distributed continuous data and Spearman (rs) for non-normally distributed 
and point biserial correlation (rpb) for dichotomous data) were used to examine the relationships 
between environmental factors and sleep quality as measured by PSG and patient self-report 
(RCSQ).  
In order to ‘quantify’ PSG sleep quality we used the TST divided by the number of sleep periods (PSG 
sleep period time ratio). We chose this in order to accommodate for the lack of independence of each 
sleep period (even small amounts of slow wave sleep suppress the propensity to sleep afterwards) 
and the slight variation in recording times between patients. We also selected this in preference to 
using the arousal index because in most patients sleep periods were short (a few minutes) and 
therefore the arousal index was (artificially) low. We theorised arousal index would not be a good 
indication of sleep quality. There were also insufficient amounts (numbers of patients who 
experienced) of slow wave and REM sleep to use these variables in multivariate analysis. Patient self-
report of sleep quality was defined as the total score for the RCSQ which was administered after the 
PSG equipment was removed in ICU. 
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A linear regression model was specified to assess the influence of intrinsic and extrinsic factors on 
sleep quality as measured by the PSG sleep period time ratio; the model included predictors most 
highly rated by patients as sleep disruptive (that is sound and illuminance levels). The outcome was 
PSG sleep period time ratio and the predictors were: number of sounds peaks >100 dB(C), presence 
of an artificial airway during sleep monitoring, administration of benzodiazepine medications and 
median daytime (06.00-21.00hrs) illuminance level during PSG sleep monitoring.  
< first level heading > Results  
< Second level heading > Patient demographic characteristics and PSG summary statistics 
The patients were predominately male and the majority were admitted to ICU with a nonoperative 
diagnosis (see Table E1. supplementary material).  
Results of the ISI indicate that few patients were troubled with significant symptoms of insomnia prior 
to hospitalisation. However sleep monitoring with PSG indicated that sleep when they were in the ICU 
was highly fragmented and the quality was poor (little slow wave and REM sleep). Self-reported sleep 
quality was significantly poorer in the ICU than prior to hospitalisation (SICQ: 7.06 ± 2.52 versus 4.50 
± 2.14, p = <0.05). The patients also reported poor sleep on the RCSQ (see Table E2. Supplementary 
material). 
< Second level heading > Extrinsic sleep disruptive factors  
Patients rated noise and light as the most sleep disruptive in ICU (Table 1). Continuous equivalent 
(56.60 ± 2.16 dB(A)) and background sound levels exceeded WHO standards on sound levels in 
hospital (47.20 ± 3.41 dB(A)). Illuminance levels were appropriate at night (median: 1 lux) but too dim 
for normal circadian rhythm during the daytime (median: 74 lux) (Table 1). The minimum median lux 
level was 23.35 lux and the maximum was 351.00 lux. (Sixteen patients were exposed to a median 
daytime lux level of 100 or above). 
< Second level heading > Intrinsic sleep disruptive factors 
There were a limited number of potentially sleep disruptive intrinsic factors that were clinically 
significant, for example mean pain score was low at <2/10 and mean anxiety level was low. However 
approximately half of the patients had an artificial airway in situ during sleep recording and a third of 
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the sample were administered benzodiazepine medication during sleep recording (see Table E3. 
supplementary material). Both of these intrinsic factors were included in the regression model. 
< Second level heading > Associations between sleep disruptive factors and quantitative and 
subjective sleep quality outcomes 
The presence of an artificial airway during sleep monitoring was positively associated with the PSG 
sleep period time ratio (rpb = 0.40, p= 0.004) (that is the presence of an artificial airway was associated 
with less sleep disruption); all other potential sleep disruptive factors were poorly associated with the 
PSG sleep period time ratio (for example the administration of benzodiazepine medications: rpb = 
0.10, p = 0.502, the number of sound peaks >100dB(C) during PSG recording: r = -0.18, p=0.228 and 
median daytime (06.00-21.00hrs) illuminance level: rs = 0.02, p=0.876). 
There were no strong associations between subjective sleep quality in ICU (total RCSQ score)
 
and 
potential sleep disruptive factors. The correlation coefficients with the total RCSQ score were low, for 
example for the number of sound peaks >100dB(C): r = -0.19, p = 0.279, administration of 
benzodiazepine medications: rpb  = -0.21, p = 0.184 and presence of an artificial airway: rpb = 0.13, p = 
0.425. 
A multiple regression model was developed to assess the effects of each of these variables on sleep 
quality. The predictor variables used in the model were the number of sound peaks >100dB(C), the 
presence of an artificial airway, administration of benzodiazepine medications and the median 
daytime (06.00-21.00hrs) illuminance level during PSG sleep recording; the dependent variable was 
PSG sleep period time ratio. The model explained 25% of the variance in sleep quality (p =0.027); the 
presence of an artificial airway was the only statistically significant predictor in the model (p = 0.007) 
(Table 2). 
<first level heading> Discussion 
There was evidence of considerable sleep disruption in this cohort of ICU patients. Both qualitative 
and quantitative measures of sleep indicated that sleep quality was poor; it was highly fragmented, 
there was little slow wave and REM sleep and patients’ self-reports indicated sleep was poor. These 
findings are comparable to the results of studies over the past three decades examining sleep in ICU 
patients (2, 9-11). 
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One of the aims of the current study was to examine the relationships between the extrinsic and 
intrinsic factors affecting sleep quality in order to elucidate the main source of sleep disruption. The 
patients rated noise and light levels as the most sleep disruptive on the SICQ and sound pressure 
levels were higher than the WHO standards for hospitals (12). In addition illuminance levels were not 
conducive to the encouragement of normal circadian rhythm; a median 74 lux (sixteen patients in the 
sample were exposed to a median lux level of 100 and above; the maximum was 351 lux) is not 
sufficiently bright during daytime hours. A daytime lux level of 100 or higher is considered sufficient to 
suppress melatonin secretion and encourage normal circadian rhythm in most individuals (13). The 
use of mechanical ventilation is a known impediment to sleep in ICU patients (14). Medications, 
especially benzodiazepines, are commonly used to induce sleep but are widely understood to 
suppress slow wave and REM sleep (15). However the only significant correlation between sleep 
quality and potentially sleep disruptive factor was the ‘presence of an artificial airway during sleep 
monitoring’. This relationship was positive indicating that sleep quality may be better in the presence 
of an artificial airway. This is surprising because even though the patients in the current study did not 
specify the presence of an artificial airway as sleep disruptive there are frequent reports by patients in 
the international literature of the discomfort associated with artificial airways particularly the 
endotracheal (ET) tube (16-18). For example in a study in which former ICU patients were interviewed 
while still in hospital 68% remembered the discomfort associated with the ET tube and one third of the 
patients remembered that ET associated discomfort interfered with their sleep (16).  
The other aim of the study was to develop a regression model to explain the variance in sleep quality 
in ICU patients. A regression model was fitted; a quantitative measure of sleep quality (the ratio 
between the number of sleep periods without waking and the total sleep time) was the dependent 
variable and the predictor variables were two intrinsic factors and factors that the patients had rated 
as most sleep disruptive that is, noise and light. Interestingly we found that the presence of an 
artificial airway during sleep monitoring was the only variable with a large regression coefficient which 
was statistically significant but sleep was not found to be related to sedation level measured by the 
VICS (rs = -0.21, p=0.13) or receipt of benzodiazepine medication (rpb = 0.10, p = 0.502). We are 
unsure whether this is an anomalous result that cannot be explained or there is some potential 
explanation that needs further exploration.  
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This study has several limitations, the primary being the sample size. Polysomnography is a 
challenging and labour intensive technique when employed to assess sleep in the critically ill. Our 
study comprised one of the larger sample sizes but there was still considerable variation in 
demographic and clinical characteristics between patients. Sleep was measured once during the ICU 
patients’ stay in ICU (in one ICU). Serial (or continuous) measurements may have provided a more 
complete picture of sleep disruptive factors. Intrinsic and extrinsic factors vary greatly during the 
illness trajectory for example plasma inflammatory mediator levels may be higher, the use of 
mechanical ventilation is more frequent and activity levels and (concomitant) sound levels tend to be 
higher during the acute phase. (The ability to measure PSG continuously throughout the patient’s ICU 
stay was limited by the availability of human and equipment resources). Absolutely precise 
synchronisation of the environmental illuminance and sound level monitoring equipment with the PSG 
recorder would have provided the opportunity to explore the relationship of awakenings with changes 
in these parameters. However the resources were not available to do this either. 
It is likely for many reasons that our model was not well specified. There are many other factors in 
ICU likely to affect sleep (the model explained 25% of the variation in the sleep quality) and our 
sample size was small, though larger than many in other ICU sleep studies. It is also likely that there 
is a non-linear relationship between sleep quality and quantity and the many factors affecting sleep in 
ICU. For example the effect of mechanical ventilation and sedative medications on sleep may be 
associated during procedures or during the acute phase of illness but not at other times. This type of 
relationship would be difficult to explore for one 24 hour episode of sleep monitoring during the 
patients’ treatment in ICU. It is possible that the sleep disruptive factors are interrelated and therefore 
associations are difficult to measure and assess. There is considerable difficulty measuring sleep in 
ICU patients and exploring factors affecting sleep quality in this population. Interrater reliability for 
sleep was moderate for sleep technicians (1) so this unlikely to be the whole explanation (that is 
classifying sleep when the patient was just behaviourally ‘still’). Although the interrater reliability for 
the analysis of sleep data was moderate (1), there remains the possibility that some data were 
misinterpreted; EEG anomalies were present in our data and there are known problems with 
conventional sleep scoring in this population (19). 
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There is current comment from ICU sleep researchers concerning the definition of sleep (or 
restorative state) and the most appropriate method of measuring it in ICU patients (19, 20). Arguably 
until this is clearly elucidated it will be difficult to be fully confident of the significant causes 
(contributing factors) for sleep disruption in ICU patients. While this important work is undertaken 
clinicians may look to evidence from epidemiological studies for suggestions on how the ICU 
environment may be made more conducive to rest and sleep, for example the sleep disruptive effects 
of aeroplane noise (21). In addition, the discipline of sleep medicine has much to offer such as 
findings from research into the effects of hypnotics and sedatives (15, 22).   
<first level heading> Conclusion  
Our study reconfirms and extends the findings of researchers investigating sleep in ICU patients. We 
developed a regression model to explore the effect of intrinsic and extrinsic factors on sleep in ICU 
patients. The results support findings from previous publications exploring this phenomenon, that is 
the assessment of sleep and factors affecting it is problematic in the ICU setting.  
The specified model explained 25% of the variation in sleep quality (defined as the TST divided by the 
number of sleep periods). Surprisingly, the presence of an artificial airway during sleep monitoring 
had the largest positive effect after controlling for the other variables. This may suggest that although 
often a source of discomfort, an artificial airway may actually promote sleep. However, this requires 
further investigation to elucidate a possible underlying mechanism. 
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Tables 
Table 1. Potential sleep disturbing factors 
  
Patient self reports SICQ item Mean ± SD, 0-10 
Noise  5.70 ± 2.75 
Light 5.15 ± 2.61 
Nursing interventions 5.05 ± 2.44 
Diagnostic testing 4.49 ± 2.67 
Vital signs 4.25 ± 2.12 
Blood samples 4.01 ± 2.20 
Administration of medications 3.84 ± 2.12 
Environmental sound and illuminance levels  
Sound (n=49)  
Leq
a
 mean ± SD, dB(A) 56.60 ± 2.16 
LF
b
 mean ± SD, dB(A) 47.20 ± 3.41 
Lpeak
c
, mean ± SD, dB(C) 107.33 ± 10.32 
Sound peaks >100dB(C) per recording, mean ± SD, n 13.20 ± 10.37 
Illuminance level (n = 45)  




], lux 74.20 [43.54-139.80] 
Highest illuminance level during daytime, lux 3230.00 
Lowest illuminance level during daytime, lux 0.06 




], lux 1.7 [1.13-2.52] 
Highest illuminance level during night-time, lux 285.00 
Lowest illuminance level during night-time, lux 0.00 
Leq
a
 = continuous equivalent sound level, LF
b
 = background sound level, Lpeak
c
 = peak sound 
pressure level, Daytime
d
 = 0600-2100hrs, IQR
e
 = interquartile range, night-time
f
 = 2100-060hrs 
  
Table(s)
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Table 2. Multivariate analysis: Regression model of the influence of intrinsic and extrinsic factors on 




number of sound peaks >100dB(C) -0.09 0.366 
presence of an artificial airway during sleep monitoring 6.82 0.007 
administration of benzodiazepine medications 1.07 0.678 
median daytime (06.00-21.00hrs) illuminance level 0.02 0.137 
dependent variable = PSG sleep period time ratio, R
2
 = 0.246, p = 0.027 
 
 
Supplementary material  
Table E1. Patient demographic characteristics  
Characteristic Statistic 
Age, mean ± SD
a
, years 58.74 ± 20.67 
Severity of illness (APACHE
b
 II) score, mean ± SD 18.70 ± 8.20 
Male gender, n [%] 36 [68]  
Nonoperative diagnosis, n [%] 35 [84] 
SD
a
 = standard deviation, APACHE
b
 = acute physiology and chronic health evaluation 
Table E2. Selected statistics for sleep quality 





], hh:mm 05:00 [02:52-07:14] 
 Stage 1 and 2, median [IQR], % 96.80 [91.70-100.00] 
 Stage 3 median [IQR], % 0.00 [0.00-1.05] 
 REM
c
 median [IQR], % 0.00 [0.00-6.00] 
 Sleep periods during recording period, median [IQR], n 38.00 [19.00-56.50] 
 PSG sleep period time ratio
d
, mean ± SD, n 6.75 [4.32-12.20] 
Subjective reports of sleep quality   
 ISI
e
 median [IQR] 5.50 [1.00-13.75] 
 ISI, ≥15, n [%] 10 [19] 
 SICQ
f 
(at home), mean ± SD
g
 7.06 ± 2.52 
 SICQ (ICU), mean ± SD 4.50 ± 2.14 
 RCSQ
h
 (ICU), mean ± SD, mm 51.36 ± 24.42 
a
TST = total sleep time, IQR
b 
= interquartile range, REM
c
 = Rapid eye movement, PSG sleep period 
time ratio
d
 = the ratio of TST divided by the number of sleep periods, ISI
e
 = Insomnia Severity Index 
(higher scores indicate more insomnia symptoms), SICQ
f 
= Sleep in Intensive Care Questonnaire (0-
10, 10 is excellent), SD
g
 = standard deviation RCSQ
h
 = Richard Campbell Sleep Questionnaire (0-
100, 100 is better) 
  
Supplemental Material
Table E3. Patient clinical characteristics 
Factor Statistic 
Pain score, mean ± SD
a
, 1-10 1.87 ± 2.66 
Sedation level VICS
b
 Interaction score, mean ± SD 27.06 ± 3.80 
Sedation level VICS Calmness score, mean ± SD 29.00 ± 2.70 
Anxiety (FAS
c
) score, mean ± SD 2.83 ± 1.30 
Patients receiving benzodiazepine medication, n [%] 16 [30] 





 = standard deviation, VICS
b 
= Vancouver Interaction and Calmness Scale, FAS
c
 = Faces Anxiety 
Scale 
 
